Cardiovascular – Hypogonadism is a condition characterized by low levels of
testosterone in men, often accompanied by various cardiovascular issues
Cardiovascular –
Hypogonadism Research Study
Late-onset hypogonadism, a condition characterized by lower-than-normal levels of testosterone in men aged 40 to 70, affects approximately 30 to 40% of individuals within this age range. Recognizing the significance of this condition, Koch Research undertook clinical research to evaluate the safety and efficacy of an investigational drug aimed at addressing late-onset hypogonadism. Through rigorous clinical trials, Koch Research aims to contribute valuable insights into the management and treatment of this prevalent condition, potentially offering new therapeutic options for affected individuals.
Current Status
Not Recruiting
Total Studies
01
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.
